Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries

Autor: Miguel Á. Canales Albendea, Pier Luigi Canonico, Guillaume Cartron, Barthold Deiters, Claudio Jommi, Reinhard Marks, Catherine Rioufol, Juan M. Sancho Cia, Armando Santoro, Eva M. Wagner-Drouet

Publikováno v: Frontiers in Medicine, Vol 10 (2023)

IntroductionCAR T-cell therapy has emerged as a promising new immuno-oncology treatment that engages the patient’s immune system to fight certain hematological malignancies, including diffuse large B-cell lymphoma (DLBCL). In the European Union (EU

Externí odkaz: https://doaj.org/article/c8df2e3381f24b3992a5551e93803778

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Autor: Alexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, Fina Climent, Eva González-Barca, Santiago Mercadal, Íñigo Espinosa, Silvana Novelli, Javier Briones, José L. Mate, Olga Salamero, Juan M. Sancho, Leonor Arenillas, Sergi Serrano, Nadina Erill, Daniel Martínez, Paola Castillo, Jordina Rovira, Antonio Martínez, Elias Campo, Luis Colomo

Publikováno v: Haematologica, Vol 98, Iss 10 (2013)

MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little information regarding the impact of numerical alterations and protein expression. We analyzed t

Externí odkaz: https://doaj.org/article/ca32524d4f854f72b22c528f64425124

Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era

Autor: Ivan Dlouhy, Pablo Mozas, Miriam Moreno-Velázquez, Eva Giné, Alfredo Rivas-Delgado, Olga Balagué, Neus Villamor, Tycho Baumann, Antonio Martínez, Juan M. Sancho-Cia, Jordina Rovira, Armando López-Guillermo, Laura Magnano, Ferran Nadeu, Blanca Gonzalez-Farre, Olga García, Julio Delgado, Elias Campo

Publikováno v: British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Follicular lymphoma (FL) is an indolent disease characterized by long survival but frequent relapses. Before the introduction of rituximab, the clinical course of these patients showed a shorter response duration (RD) after each relapse. In this stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0368eca47a57ff74e8f2fd07a938afd
https://doi.org/10.1111/bjh.15708

Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm

Autor: Carlos, Montalbán, Antonio, Díaz-López, Alejandro, Martín, Mónica, Baile, José M, Sanchez, Juan M, Sancho, Olga, García, Silvana, Novelli, Anna, Monter-Rovira, Antonio, Salar, Mariana, Bastos, Antonio, Gutiérrez, Leyre, Bento, Raul, Córdoba, Teresa, Arquero, Sonia, González de Villambrosia, Gilberto, Barranco, Raquel, De Oña, Armando, López Guillermo, María J, Rodriguez Salazar, Juan F, Domínguez, Rubén, Fernández, José A, Queizan, José, Rodríguez, Victor, Abraira, Juan F, García, María, Casanova

Publikováno v: BRITISH JOURNAL OF HAEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

The Grupo Espanol de Linfomas y Trasplantes de Medula Osea International Prognostic Index (GELTAMO-IPI) stratifies four risk groups in diffuse large B cell lymphoma (DLBCL) patients treated with immunochaemotherapy: low (LR), low-intermediate (LIR),

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1686edf004f83af8a0d1fb6f1a7eed9
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3467

Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy

Autor: Carmen Fernandez-Alvarez, Arturo Rubio-Castro, Ana P Gonzalez-Rodriguez, Jackeline Solano, Ruben Fernández-Álvarez, Angel Ramirez Payer, Jesus E. Medina, Jose Manuel Alonso, M. Esther Gonzalez, Yahya Zanabili, Eva Alonso-Nogues, José Vicente, Juan M. Sancho, Francisco Dominguez-Iglesias

Publikováno v: Leukemia & Lymphoma. 56:3096-3102

Ferritin levels might correlate with disease activity in classical Hodgkin lymphoma (cHL). We analyzed the prognostic significance of the ferritin value at diagnosis in 173 cHL patients treated with ABVD between 2003 and 2013. The 5-year overall surv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::366b69185194f0d43543d8e7babb46db
https://doi.org/10.3109/10428194.2015.1038709